Can antivirals help us defeat coronavirus? The odds don’t look good. The use of antiviral compounds against respiratory viruses has a chequered history. Hundreds have been tested; very few have made it to market. And even fewer make a difference. What’s more, the evidence of their impact on mortality rates – the most important outcome of all – is thin.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk